Thierry Briand

Title: Thierry Briand: Innovator in Endothelin Receptor Antagonists

Introduction

Thierry Briand is a notable inventor based in Huningue, France. He has made significant contributions to the field of pharmaceuticals, particularly in the development of endothelin receptor antagonists. His work has led to the creation of innovative compounds that have potential therapeutic applications.

Latest Patents

Thierry Briand holds a patent for "Crystalline forms of a pyridinyl-sulfonamide and their use as endothelin receptor antagonists." This patent describes crystalline forms A and B of 5-methyl-pyridine-2-sulfonic acid [6-methoxy-5-(2-methoxy-phenoxy)-2-pyridin-4-yl-pyrimidin-4-yl]-amide of formula (I). Notably, form B is recognized as the most stable form. Additionally, the compound forms solvates with various solvents, including ethanol, acetone, tetrahydrofuran, methanol, isopropanol, 2-butanone, and dichloromethane.

Career Highlights

Thierry Briand is associated with Speedel Pharma AG, a company known for its focus on innovative pharmaceutical solutions. His work at Speedel Pharma AG has been instrumental in advancing research in the field of endothelin receptor antagonists.

Collaborations

Thierry has collaborated with notable colleagues, including Alexander Bilz and Fritz Blatter. Their combined expertise has contributed to the successful development of innovative pharmaceutical products.

Conclusion

Thierry Briand's contributions to the field of pharmaceuticals, particularly through his patent on endothelin receptor antagonists, highlight his role as an influential inventor. His work continues to pave the way for advancements in medical treatments.